Fundraising FoxClovis Oncology
5 known investors
Find your way into Clovis Oncology
Sign up to find every way you can get introduced to Clovis Oncology
- Your email: who you already know at Clovis Oncology, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Clovis Oncology team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Developed targeted cancer therapies with companion diagnostics (Rubraca); IPO'd in 2011 (NASDAQ: CLVS).
Founders & leadership
Investors · 5
Aisling Capitallisted by Aisling CapitalNew York
How we know: Aisling Capital's portfolio page · Not right? Tell us
Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto
How we know: Frazier Life Sciences's portfolio page · Not right? Tell us
Frequently asked questions
- What does Clovis Oncology do?
- Developed targeted cancer therapies with companion diagnostics (Rubraca); IPO'd in 2011 (NASDAQ: CLVS).
- Who founded Clovis Oncology?
- Clovis Oncology was founded by Patrick Mahaffy.
- Who are Clovis Oncology's investors?
- Clovis Oncology's investors include Aisling Capital, Frazier Life Sciences, New Enterprise Associates (NEA), Pfizer Venture Investments, Ridgeback Capital.